title: Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies.
authors: Emilien
authors: E
authors: Delmont
authors: P Y
authors: PY
authors: Jeandel
authors: C
authors: C
authors: Benaïm
authors: E
authors: E
authors: Rosenthal
authors: J G
authors: JG
authors: Fuzibet
authors: C
authors: C
authors: Desnuelle
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001323:Autoantibodies / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018992:Myelin-Associated Glycoprotein / Q000276:immunology*; D011115:Polyneuropathies / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D001323:Autoantibodies; D018992:Myelin-Associated Glycoprotein; D000069283:Rituximab